Geneva, May 4 -- International Clinical Trials Registry received information related to the study (CTRI/2026/04/109314) titled 'Testing a skincare serum ( Demelan Nexa Serum) on healthy people to make sure it doesn t clog pores or cause acne where everyone knows what they are using' on April 24.

Study Type: Interventional

Study Design: Single Arm Study Method of generating randomization sequence:Not Applicable Method of allocation concealment:Not Applicable Blinding and masking:Not Applicable

Primary Sponsor: ERIS LIFESCIENCES LIMITED

Intervention: Intervention1: Demelan Nexa Serum: The product will be applied daily once daily of face for 28 Days Control Intervention1: NIL: NIL

Recruitment Status: Not Recruiting

Phase: N/A ...